CRISPR Therapeutics AG (NASDAQ: CRSP) is one of the 10 most shorted biotech stocks to buy according to hedge funds. On February 17, Morgan Stanley increased its price target on CRISPR Therapeutics AG ...

2025 was a year characterized by both challenges and opportunities for the biotechnology sector. Despite volatility, the segment remained on a high-growth trajectory, driven by several clinical and ...

Biotech stocks continue to outperform in the current stock market rally, as Dow Jones index component and industry giant AmgenAMGN, along with Gilead SciencesGILD, Vertex PharmaceuticalsVRTX, ...

Bell Potter thinks this biotech could be working on something very big. The post Broker says this exciting ASX biotech stock could rise almost 50% appeared first on The Motley Fool Australia.

Healthcare stocks rallied in 2025, breaking a two-year slump as investors chased steadier rates, better valuations, and improving earnings. The problem: mid-single-digit gains still lagged tech, ...

Biotech stocks have rallied strongly into 2026, building on the late-2025 momentum from positive clinical data, cheaper valuation, easy money policy and favorable macro conditions. Biotech-based ...

Direxion Biotech Bull 3X (LABU) doubled over the past year by delivering three times the daily biotech index return. FDA drug approvals often trigger 20% to 50% single-day stock jumps that LABU’s ...

Buying biotech stocks is a great way to add growth to your portfolio. This particular player won approval for its first product a couple of years ago, proving the strength of its game-changing ...

Learning how to trade biotech stocks offers some of the most explosive profit opportunities in the entire market—but also some of its most punishing risks. Biotech stocks can double or triple ...